Quince therapeutics to present at oppenheimer 35th annual healthcare life sciences conference

South san francisco, calif.--(business wire)---- $qncx #biotech--quince therapeutics, inc. (nasdaq: qncx), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that dirk thye, m.d., quince's chief executive officer and chief medical officer, will participate in a fireside chat at the oppenheimer 35th annual healthcare life sciences conference, a virtual event, on wednesday, february 12, 2025 beginning at 2:00 p.m. easter.
QNCX Ratings Summary
QNCX Quant Ranking